Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gem-TIP for Relapsed Germ Cell Cancer
NCT00551122Phase 2Unknown
- Sponsor
- University of Southampton
- Start
- Nov 2006
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in germ cell tumor (GCT), sponsored by University of Southampton. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00551122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00551122.